In this Nov. 6, 2019, file photo, Kanye West attends the WSJ. Magazine 2019 Innovator Awards at the Museum of Modern Art in New York. The rap superstar will design adult and kids' clothing that will be sold at Gap in 2021. Yeezy is best known for pricey sneakers that sell out online quickly. But Yeezy footwear, made with sneaker company Adidas, won't be sold at Gap. (Photo by Evan Agostini/Invision/AP, File)
By Joseph Pisani
Kanye West is bringing his Yeezy brand to Gap.
The rap superstar will design adult and kids' clothing that will be sold at the chain's stores next year. Yeezy is best known for pricey sneakers that sell out online quickly. But Yeezy footwear, made with sneaker company Adidas, won't be sold at Gap stores.
San Francisco-based Gap Inc., whose sales are dwindling, hopes the deal will keep it relevant with shoppers. For Yeezy, being in more than 1,100 stores worldwide could get the brand in front of more people.
On Friday, West tweeted a photo of what the collaboration might look like: bright colored hoodies, jackets, and T-shirts.
West has a history with Gap. He worked at one of its stores in Chicago as a teenager. And he told Vanity Fair magazine back in 2015 that he wanted to be creative director of the brand.
As part of the deal announced Friday, Yeezy will receive royalties and possibly Gap stock if the line sells well.
Shares of the retailer jumped 16% in premarket trading.
One company shaking up the startup space is Super.com, which aims to help everyday Americans save money and access credit. Hussein Fazal, CEO and co-founder, joins Cheddar News to break down how the product works.
Disgraced Theranos CEO Elizabeth Holmes is in custody at a Texas prison where she could spend the next 11 years for overseeing a blood-testing hoax that became a parable about greed and hubris in Silicon Valley, according to the Federal Bureau of Prisons.
Wall Street is ticking higher Tuesday in its first trading after Washington struck a tentative deal to avoid a potentially disastrous default on its debt.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
